Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $10.2100 (-7.14%) ($10.1800 - $10.2100) on Wed. Dec. 20, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.24% (three month average) | RSI | 49 | Latest Price | $10.2100(-7.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.3% a day on average for past five trading days. | Weekly Trend | EDIT declines -0.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) DIA(99%) XBI(95%) LIT(87%) IVE(86%) ARKG(85%) | Factors Impacting EDIT price | EDIT will decline at least -2.62% in a week (0% probabilities). VXX(-44%) BNDX(-29%) VIXM(-28%) TBT(-24%) URA(5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.62% (StdDev 5.24%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $10.61 | 5 Day Moving Average | $10.68(-4.4%) | 10 Day Moving Average | $10.49(-2.67%) | 20 Day Moving Average | $10.61(-3.77%) | To recent high | -7.9% | To recent low | 63.1% | Market Cap | $634m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |